
zzso survival is an important end point in advanced disease zzso zzso independent central review zzso of progression in zzso clinical trials has been advocated to control bias that might result from errors in progression zzso However, although zzso zzso some potential zzso it does not remove all biases from evaluations of treatment zzso In fact, as typically conducted, zzso may introduce bias because of zzso zzso which results from having to censor zzso locally determined zzso In this article, we discuss the rationale for zzso and different ways of implementing independent zzso We discuss the limitations of these approaches and review published trials that report implementing zzso We demonstrate the existence of zzso zzso using data from a zzso phase II zzso We conclude that zzso trials with consistent application of measurement criteria are the best means of ensuring unbiased trial zzso When such designs are not practical, zzso is not recommended as a general strategy for reducing zzso However, zzso may be useful as an auditing tool to assess the reliability of marginally positive zzso 

